We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.
Second quarter 2024 results
July 18, 2024 | Basel, Switzerland
Media release:
English (PDF 0.5 MB) | Deutsch (PDF 0.5 MB) | Français (PDF 0.5 MB)
Interim financial report (PDF 0.5 MB)
Watch the webcast
Download the podcast (MP3 34 MB)
Download the presentation (PDF 5.5 MB)
Read the transcript
Novartis Q2 2024 impact and sustainability update (PDF 0.9 MB)
Investors event calendar
View recent presentations and learn more about upcoming events.
September 05, 2024
Morgan Stanley Global Healthcare Conference
New York, USA
Environmental, Social and Governance (ESG)
Novartis aims to hold itself to the highest standards of sustainability and ethical business practices. We take bold steps to increase access to medicines, tackle complex global health challenges, and do our part as a responsible corporate citizen.
ESG updates: July 2024 (PDF 0.9 MB) | April 2024 (PDF 1.0 MB) | February 2024 (PDF 0.6 MB) | November 2023 (PDF 1.0 MB)
Latest updates: Impact & Health Equity (PDF 9.9 MB) | Novartis Enterprise Risk Management (PDF 0.2 MB) | Materiality Assessment
We have created a set of environmental, social and governance indices to signpost where our key disclosures can be found across our publications and channels. Novartis aims to report comprehensively and transparently for all stakeholders concerned with ESG topics.
Stocks
Reporting and transparency hub
Read our regulatory filings; policies, codes and guidelines that govern our activities; and environmental, social and governance (ESG) disclosures.